You are here

CVC, Temasek 'exploring options' for Alvogen

Hong Kong

ALVOGEN'S owners - including CVC Capital Partners and Temasek Holdings - are said to be exploring options for the generic pharmaceutical company, which could be valued at about US$4 billion, according to people familiar with the matter.

The...

sentifi.com

Market voices on: